Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Symphogen A/S
DescriptionAntibody targeting an undisclosed infectious disease target
Molecular Target Undisclosed
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard Indication Infectious (unspecified)
Indication DetailsTreat undisclosed infectious disease
Regulatory Designation
PartnerGenentech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today